Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

APARNA R PARIKH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1154557650
CMS profile
396081
Location
BOSTON, MA

General Payments · PY2018–2024

$152,057.70

  • Reported across 129 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$49,447.63

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $43,804.00 13
Travel and Lodging $4,761.62 22
Food and Beverage $882.01 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $9,901.21 4
Takeda Pharmaceuticals U.S.A., Inc. $8,585.70 7
Incyte Corporation $8,241.46 12
Regeneron Pharmaceuticals, Inc. $6,893.61 9
Eli Lilly and Company $3,882.06 9
E.R. Squibb & Sons, L.L.C. $2,880.00 1
Amgen Inc. $2,744.00 1
Merck Sharp & Dohme Corporation $2,397.92 4
PFIZER INC. $1,800.00 1
Delcath Systems $1,800.00 1
Exact Sciences Corporation $183.00 1
ARRAY BIOPHARMA INC $138.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $13,890.59 10
PY2019 $125.00 1
PY2020 $5,910.61 5
PY2021 $5,737.50 3
PY2022 $25,601.25 21
PY2023 $51,345.12 38
PY2024 $49,447.63 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $2,744.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1117346602 CMS
ARRAY BIOPHARMA INC $138.67 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131738597 CMS
Delcath Systems $1,800.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1130859872 CMS
E.R. Squibb & Sons, L.L.C. $2,880.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1101640861 CMS
Eli Lilly and Company $173.10 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1136000289 CMS
Eli Lilly and Company $135.69 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1136000291 CMS
Eli Lilly and Company $416.06 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1136000293 CMS
Eli Lilly and Company $8.68 04/26/2024 Food and Beverage Undisputed 01/23/2026 1136046467 CMS
Eli Lilly and Company $193.74 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1136049341 CMS
Eli Lilly and Company $426.86 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1136061398 CMS
Eli Lilly and Company $2,400.00 05/06/2024 Consulting Fee Undisputed 01/23/2026 1136050257 CMS
Eli Lilly and Company $50.00 05/14/2024 Food and Beverage Undisputed 01/23/2026 1136050113 CMS
Eli Lilly and Company $77.93 05/14/2024 Travel and Lodging Undisputed 01/23/2026 1136051177 CMS
Exact Sciences Corporation $183.00 12/31/2024 Consulting Fee Undisputed 01/23/2026 1125639962 CMS
GlaxoSmithKline, LLC. $1,600.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1116726710 CMS
GlaxoSmithKline, LLC. $78.53 02/14/2024 Travel and Lodging Undisputed 01/23/2026 1115822608 CMS
GlaxoSmithKline, LLC. $8,000.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1116472021 CMS
GlaxoSmithKline, LLC. $222.68 03/05/2024 Travel and Lodging Undisputed 01/23/2026 1116645819 CMS
Incyte Corporation $151.09 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169089 CMS
Incyte Corporation $50.63 11/21/2024 Food and Beverage Undisputed 01/23/2026 1141169091 CMS
Incyte Corporation $45.00 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169097 CMS
Incyte Corporation $71.73 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169099 CMS
Incyte Corporation $41.66 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169105 CMS
Incyte Corporation $291.96 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141170115 CMS
Incyte Corporation $572.08 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141169085 CMS
Incyte Corporation $60.00 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169087 CMS
Incyte Corporation $46.48 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141169093 CMS
Incyte Corporation $33.84 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169101 CMS
Incyte Corporation $6,850.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1141169103 CMS
Incyte Corporation $26.99 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169469 CMS
Merck Sharp & Dohme LLC $90.00 06/04/2024 Food and Beverage Undisputed 01/23/2026 1141673281 CMS
Merck Sharp & Dohme LLC $22.92 06/04/2024 Food and Beverage Undisputed 01/23/2026 1141673283 CMS
Merck Sharp & Dohme LLC $150.00 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1141691894 CMS
Merck Sharp & Dohme LLC $2,135.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1141691896 CMS
PFIZER INC. $1,800.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 1131223766 CMS
Regeneron Pharmaceuticals, Inc. $60.36 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114403875 CMS
Regeneron Pharmaceuticals, Inc. $60.55 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114403877 CMS
Regeneron Pharmaceuticals, Inc. $54.55 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114403879 CMS
Regeneron Pharmaceuticals, Inc. $123.44 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114403881 CMS
Regeneron Pharmaceuticals, Inc. $881.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1114403883 CMS
Regeneron Pharmaceuticals, Inc. $5,286.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1114403885 CMS
Regeneron Pharmaceuticals, Inc. $409.03 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1114403887 CMS
Regeneron Pharmaceuticals, Inc. $14.45 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1114403889 CMS
Regeneron Pharmaceuticals, Inc. $4.23 03/22/2024 Food and Beverage Undisputed 01/23/2026 1114403891 CMS
Takeda Pharmaceuticals U.S.A., Inc. $76.17 08/09/2024 Food and Beverage Undisputed 01/23/2026 1144965543 CMS
Takeda Pharmaceuticals U.S.A., Inc. $710.15 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1144965545 CMS
Takeda Pharmaceuticals U.S.A., Inc. $228.66 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1144965547 CMS
Takeda Pharmaceuticals U.S.A., Inc. $207.32 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1144965549 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.98 09/20/2024 Food and Beverage Undisputed 01/23/2026 1144965551 CMS
Takeda Pharmaceuticals U.S.A., Inc. $97.42 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1144965553 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,245.00 09/20/2024 Consulting Fee Undisputed 01/23/2026 1144965555 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.